The impact of COVID-19 has been felt on all levels of society and deeply affected our lives. It has challenged us to find new ways of carrying on with our activities at home, work, and school. Jeff Small, Director and...
The impact of COVID-19 has been felt on all levels of society and deeply affected our lives. It has challenged us to find new ways of carrying on with our activities at home, work, and school. Jeff Small, Director and...
British Tinnitus Association staff members, Colette Bunker, Angela Pollard and Jess Pollard, will be completing their first ever marathon on 3 October as they take on the Virgin Money Virtual London Marathon for the charity they work for. The British...
Soluvos Medical is proud to be an official partner for COOK OHNS in the BeNeLux region, as of 1 February 2022, for the COOK OHNS product line: Sialendoscopy, Biodesign Otologic repair, Doppler Blood Flow Monitor, Biodesign Dural repair.
Neuromod Devices Ltd., has reached an agreement with HØR AS, Norway’s largest private provider of hearing and tinnitus care, to make its Lenire tinnitus treatment device available in Norway.
The family-owned medical technology company KARL STORZ announces the acquisition of 100 percent of the shares of AventaMed DAC, an Irish medical technologies company.
Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.